Global Infectious Diseases Molecular Diagnostics Market Research Report 2024

Infectious Diseases Molecular Diagnostics Market

The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.

The global Infectious Diseases Molecular Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The Infectious Diseases Molecular Diagnostics market is driven by the need for rapid and accurate diagnostics for infectious diseases and the increasing global incidence of such diseases. Molecular diagnostics offer advanced methods for detecting infectious pathogens and monitoring their genetic variations. The rise in emerging infectious diseases and the demand for point-of-care testing contribute to market growth as healthcare systems seek reliable tools for early detection and effective disease management. Moreover, advancements in diagnostic technologies, including nucleic acid amplification techniques and multiplex assays, align with improved sensitivity and specificity of infectious disease diagnosis. However, the market also faces challenges, including establishing standardized testing protocols and addressing cost barriers for widespread adoption. Additionally, ensuring accessibility and navigating regulatory approvals for new diagnostics can pose obstacles for manufacturers. To succeed, stakeholders must focus on developing innovative molecular diagnostic solutions, collaborating with public health agencies, and addressing the challenges to meet the increasing demand for rapid and accurate detection of infectious diseases.

This report aims to provide a comprehensive presentation of the global market for Infectious Diseases Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Diseases Molecular Diagnostics.

Report Scope

The Infectious Diseases Molecular Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Diseases Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Infectious Diseases Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Roche

Qiagen

Illumina

Abbott

Hologic

BioMerieux

Danaher (Cepheid)

Myriad Genetics

DAAN Gene

Agilent

Genomic Health

BD

Foundation Medicine

Polymerase Chain Reaction PCR

Molecular Hybridization

Biochip

Others

Hospital

Third-party Testing Agency

Others

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Scope of Infectious Diseases Molecular Diagnostics Market Report

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Infectious Diseases Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Polymerase Chain Reaction PCR

1.2.3 Molecular Hybridization

1.2.4 Biochip

1.2.5 Others

1.3 Market by Application

1.3.1 Global Infectious Diseases Molecular Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Third-party Testing Agency

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Infectious Diseases Molecular Diagnostics Market Perspective (2019-2030)

2.2 Infectious Diseases Molecular Diagnostics Growth Trends by Region

2.2.1 Global Infectious Diseases Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Infectious Diseases Molecular Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Infectious Diseases Molecular Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Infectious Diseases Molecular Diagnostics Market Dynamics

2.3.1 Infectious Diseases Molecular Diagnostics Industry Trends

2.3.2 Infectious Diseases Molecular Diagnostics Market Drivers

2.3.3 Infectious Diseases Molecular Diagnostics Market Challenges

2.3.4 Infectious Diseases Molecular Diagnostics Market Restraints

3.1 Global Top Infectious Diseases Molecular Diagnostics Players by Revenue

3.1.1 Global Top Infectious Diseases Molecular Diagnostics Players by Revenue (2019-2024)

3.1.2 Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Infectious Diseases Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Infectious Diseases Molecular Diagnostics Revenue

3.4 Global Infectious Diseases Molecular Diagnostics Market Concentration Ratio

3.4.1 Global Infectious Diseases Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases Molecular Diagnostics Revenue in 2023

3.5 Infectious Diseases Molecular Diagnostics Key Players Head office and Area Served

3.6 Key Players Infectious Diseases Molecular Diagnostics Product Solution and Service

3.7 Date of Enter into Infectious Diseases Molecular Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Infectious Diseases Molecular Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Type (2025-2030)

5.1 Global Infectious Diseases Molecular Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Application (2025-2030)

6.1 North America Infectious Diseases Molecular Diagnostics Market Size (2019-2030)

6.2 North America Infectious Diseases Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Infectious Diseases Molecular Diagnostics Market Size by Country (2019-2024)

6.4 North America Infectious Diseases Molecular Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7.1 Europe Infectious Diseases Molecular Diagnostics Market Size (2019-2030)

7.2 Europe Infectious Diseases Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2019-2024)

7.4 Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Infectious Diseases Molecular Diagnostics Market Size (2019-2030)

9.2 Latin America Infectious Diseases Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Infectious Diseases Molecular Diagnostics Market Size by Country (2019-2024)

9.4 Latin America Infectious Diseases Molecular Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Roche

11.1.1 Roche Company Detail

11.1.2 Roche Business Overview

11.1.3 Roche Infectious Diseases Molecular Diagnostics Introduction

11.1.4 Roche Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024)

11.1.5 Roche Recent Development

11.2 Qiagen

11.2.1 Qiagen Company Detail

11.2.2 Qiagen Business Overview

11.2.3 Qiagen Infectious Diseases Molecular Diagnostics Introduction

11.2.4 Qiagen Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024)

11.2.5 Qiagen Recent Development

11.3 Illumina

11.3.1 Illumina Company Detail

11.3.2 Illumina Business Overview

11.3.3 Illumina Infectious Diseases Molecular Diagnostics Introduction

11.3.4 Illumina Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024)

11.3.5 Illumina Recent Development

11.4 Abbott

11.4.1 Abbott Company Detail

11.4.2 Abbott Business Overview

11.4.3 Abbott Infectious Diseases Molecular Diagnostics Introduction

11.4.4 Abbott Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024)

11.4.5 Abbott Recent Development

11.5 Hologic

11.5.1 Hologic Company Detail

11.5.2 Hologic Business Overview

11.5.3 Hologic Infectious Diseases Molecular Diagnostics Introduction

11.5.4 Hologic Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024)

11.5.5 Hologic Recent Development

11.6 BioMerieux

11.6.1 BioMerieux Company Detail

11.6.2 BioMerieux Business Overview

11.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Introduction

11.6.4 BioMerieux Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024)

11.6.5 BioMerieux Recent Development

11.7 Danaher (Cepheid)

11.7.1 Danaher (Cepheid) Company Detail

11.7.2 Danaher (Cepheid) Business Overview

11.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Introduction

11.7.4 Danaher (Cepheid) Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024)

11.7.5 Danaher (Cepheid) Recent Development

11.8 Myriad Genetics

11.8.1 Myriad Genetics Company Detail

11.8.2 Myriad Genetics Business Overview

11.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Introduction

11.8.4 Myriad Genetics Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024)

11.8.5 Myriad Genetics Recent Development

11.9 DAAN Gene

11.9.1 DAAN Gene Company Detail

11.9.2 DAAN Gene Business Overview

11.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Introduction

11.9.4 DAAN Gene Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024)

11.9.5 DAAN Gene Recent Development

11.10 Agilent

11.10.1 Agilent Company Detail

11.10.2 Agilent Business Overview

11.10.3 Agilent Infectious Diseases Molecular Diagnostics Introduction

11.10.4 Agilent Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024)

11.10.5 Agilent Recent Development

11.11 Genomic Health

11.11.1 Genomic Health Company Detail

11.11.2 Genomic Health Business Overview

11.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Introduction

11.11.4 Genomic Health Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024)

11.11.5 Genomic Health Recent Development

11.12 BD

11.12.1 BD Company Detail

11.12.2 BD Business Overview

11.12.3 BD Infectious Diseases Molecular Diagnostics Introduction

11.12.4 BD Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024)

11.12.5 BD Recent Development

11.13 Foundation Medicine

11.13.1 Foundation Medicine Company Detail

11.13.2 Foundation Medicine Business Overview

11.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Introduction

11.13.4 Foundation Medicine Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024)

11.13.5 Foundation Medicine Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

    Table 2. Key Players of Polymerase Chain Reaction PCR

    Table 3. Key Players of Molecular Hybridization

    Table 4. Key Players of Biochip

    Table 5. Key Players of Others

    Table 6. Global Infectious Diseases Molecular Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

    Table 7. Global Infectious Diseases Molecular Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 8. Global Infectious Diseases Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)

    Table 9. Global Infectious Diseases Molecular Diagnostics Market Share by Region (2019-2024)

    Table 10. Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

    Table 11. Global Infectious Diseases Molecular Diagnostics Market Share by Region (2025-2030)

    Table 12. Infectious Diseases Molecular Diagnostics Market Trends

    Table 13. Infectious Diseases Molecular Diagnostics Market Drivers

    Table 14. Infectious Diseases Molecular Diagnostics Market Challenges

    Table 15. Infectious Diseases Molecular Diagnostics Market Restraints

    Table 16. Global Infectious Diseases Molecular Diagnostics Revenue by Players (2019-2024) & (US$ Million)

    Table 17. Global Infectious Diseases Molecular Diagnostics Market Share by Players (2019-2024)

    Table 18. Global Top Infectious Diseases Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics as of 2023)

    Table 19. Ranking of Global Top Infectious Diseases Molecular Diagnostics Companies by Revenue (US$ Million) in 2023

    Table 20. Global 5 Largest Players Market Share by Infectious Diseases Molecular Diagnostics Revenue (CR5 and HHI) & (2019-2024)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Infectious Diseases Molecular Diagnostics Product Solution and Service

    Table 23. Date of Enter into Infectious Diseases Molecular Diagnostics Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Infectious Diseases Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)

    Table 26. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Type (2019-2024)

    Table 27. Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

    Table 28. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Type (2025-2030)

    Table 29. Global Infectious Diseases Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)

    Table 30. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Application (2019-2024)

    Table 31. Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

    Table 32. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Application (2025-2030)

    Table 33. North America Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 34. North America Infectious Diseases Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

    Table 35. North America Infectious Diseases Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

    Table 36. Europe Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 37. Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

    Table 38. Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

    Table 39. Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 40. Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)

    Table 41. Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Region (2025-2030) & (US$ Million)

    Table 42. Latin America Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 43. Latin America Infectious Diseases Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

    Table 44. Latin America Infectious Diseases Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

    Table 45. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 46. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

    Table 47. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

    Table 48. Roche Company Detail

    Table 49. Roche Business Overview

    Table 50. Roche Infectious Diseases Molecular Diagnostics Product

    Table 51. Roche Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024) & (US$ Million)

    Table 52. Roche Recent Development

    Table 53. Qiagen Company Detail

    Table 54. Qiagen Business Overview

    Table 55. Qiagen Infectious Diseases Molecular Diagnostics Product

    Table 56. Qiagen Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024) & (US$ Million)

    Table 57. Qiagen Recent Development

    Table 58. Illumina Company Detail

    Table 59. Illumina Business Overview

    Table 60. Illumina Infectious Diseases Molecular Diagnostics Product

    Table 61. Illumina Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024) & (US$ Million)

    Table 62. Illumina Recent Development

    Table 63. Abbott Company Detail

    Table 64. Abbott Business Overview

    Table 65. Abbott Infectious Diseases Molecular Diagnostics Product

    Table 66. Abbott Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024) & (US$ Million)

    Table 67. Abbott Recent Development

    Table 68. Hologic Company Detail

    Table 69. Hologic Business Overview

    Table 70. Hologic Infectious Diseases Molecular Diagnostics Product

    Table 71. Hologic Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024) & (US$ Million)

    Table 72. Hologic Recent Development

    Table 73. BioMerieux Company Detail

    Table 74. BioMerieux Business Overview

    Table 75. BioMerieux Infectious Diseases Molecular Diagnostics Product

    Table 76. BioMerieux Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024) & (US$ Million)

    Table 77. BioMerieux Recent Development

    Table 78. Danaher (Cepheid) Company Detail

    Table 79. Danaher (Cepheid) Business Overview

    Table 80. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product

    Table 81. Danaher (Cepheid) Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024) & (US$ Million)

    Table 82. Danaher (Cepheid) Recent Development

    Table 83. Myriad Genetics Company Detail

    Table 84. Myriad Genetics Business Overview

    Table 85. Myriad Genetics Infectious Diseases Molecular Diagnostics Product

    Table 86. Myriad Genetics Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024) & (US$ Million)

    Table 87. Myriad Genetics Recent Development

    Table 88. DAAN Gene Company Detail

    Table 89. DAAN Gene Business Overview

    Table 90. DAAN Gene Infectious Diseases Molecular Diagnostics Product

    Table 91. DAAN Gene Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024) & (US$ Million)

    Table 92. DAAN Gene Recent Development

    Table 93. Agilent Company Detail

    Table 94. Agilent Business Overview

    Table 95. Agilent Infectious Diseases Molecular Diagnostics Product

    Table 96. Agilent Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024) & (US$ Million)

    Table 97. Agilent Recent Development

    Table 98. Genomic Health Company Detail

    Table 99. Genomic Health Business Overview

    Table 100. Genomic Health Infectious Diseases Molecular Diagnostics Product

    Table 101. Genomic Health Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024) & (US$ Million)

    Table 102. Genomic Health Recent Development

    Table 103. BD Company Detail

    Table 104. BD Business Overview

    Table 105. BD Infectious Diseases Molecular Diagnostics Product

    Table 106. BD Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024) & (US$ Million)

    Table 107. BD Recent Development

    Table 108. Foundation Medicine Company Detail

    Table 109. Foundation Medicine Business Overview

    Table 110. Foundation Medicine Infectious Diseases Molecular Diagnostics Product

    Table 111. Foundation Medicine Revenue in Infectious Diseases Molecular Diagnostics Business (2019-2024) & (US$ Million)

    Table 112. Foundation Medicine Recent Development

    Table 113. Research Programs/Design for This Report

    Table 114. Key Data Information from Secondary Sources

    Table 115. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Infectious Diseases Molecular Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

    Figure 2. Global Infectious Diseases Molecular Diagnostics Market Share by Type: 2023 VS 2030

    Figure 3. Polymerase Chain Reaction PCR Features

    Figure 4. Molecular Hybridization Features

    Figure 5. Biochip Features

    Figure 6. Others Features

    Figure 7. Global Infectious Diseases Molecular Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

    Figure 8. Global Infectious Diseases Molecular Diagnostics Market Share by Application: 2023 VS 2030

    Figure 9. Hospital Case Studies

    Figure 10. Third-party Testing Agency Case Studies

    Figure 11. Others Case Studies

    Figure 12. Infectious Diseases Molecular Diagnostics Report Years Considered

    Figure 13. Global Infectious Diseases Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

    Figure 14. Global Infectious Diseases Molecular Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

    Figure 15. Global Infectious Diseases Molecular Diagnostics Market Share by Region: 2023 VS 2030

    Figure 16. Global Infectious Diseases Molecular Diagnostics Market Share by Players in 2023

    Figure 17. Global Top Infectious Diseases Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics as of 2023)

    Figure 18. The Top 10 and 5 Players Market Share by Infectious Diseases Molecular Diagnostics Revenue in 2023

    Figure 19. North America Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 20. North America Infectious Diseases Molecular Diagnostics Market Share by Country (2019-2030)

    Figure 21. United States Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 22. Canada Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 23. Europe Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 24. Europe Infectious Diseases Molecular Diagnostics Market Share by Country (2019-2030)

    Figure 25. Germany Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 26. France Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 27. U.K. Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 28. Italy Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 29. Russia Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 30. Nordic Countries Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 31. Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 32. Asia-Pacific Infectious Diseases Molecular Diagnostics Market Share by Region (2019-2030)

    Figure 33. China Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 34. Japan Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 35. South Korea Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 36. Southeast Asia Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 37. India Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 38. Australia Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 39. Latin America Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 40. Latin America Infectious Diseases Molecular Diagnostics Market Share by Country (2019-2030)

    Figure 41. Mexico Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 42. Brazil Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 43. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 44. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Share by Country (2019-2030)

    Figure 45. Turkey Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 46. Saudi Arabia Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 47. Roche Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2019-2024)

    Figure 48. Qiagen Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2019-2024)

    Figure 49. Illumina Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2019-2024)

    Figure 50. Abbott Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2019-2024)

    Figure 51. Hologic Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2019-2024)

    Figure 52. BioMerieux Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2019-2024)

    Figure 53. Danaher (Cepheid) Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2019-2024)

    Figure 54. Myriad Genetics Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2019-2024)

    Figure 55. DAAN Gene Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2019-2024)

    Figure 56. Agilent Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2019-2024)

    Figure 57. Genomic Health Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2019-2024)

    Figure 58. BD Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2019-2024)

    Figure 59. Foundation Medicine Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2019-2024)

    Figure 60. Bottom-up and Top-down Approaches for This Report

    Figure 61. Data Triangulation

    Figure 62. Key Executives Interviewed